CVRX INC (CVRX) Stock Price, Forecast & Analysis
USA - NASDAQ:CVRX - US1266381052 - Common Stock
CVRX Key Statistics, Chart & Performance
The current stock price of CVRX is 10.19 USD. In the past month the price increased by 16.99%. In the past year, price decreased by -23.96%.
CVRX Latest News, Press Relases and Analysis
CVRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.77 | 215.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.05 | 191.53B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.14 | 149.24B | ||
| SYK | STRYKER CORP | 27.05 | 136.19B | ||
| MDT | MEDTRONIC PLC | 16.4 | 116.34B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 51.22B | ||
| IDXX | IDEXX LABORATORIES INC | 52.42 | 50.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.08 | 48.41B | ||
| RMD | RESMED INC | 24.94 | 36.03B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.46 | 26.31B | ||
| STE | STERIS PLC | 24.71 | 23.21B |
Related stock screener links
About CVRX
Company Profile
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Company Info
CVRX INC
9201 West Broadway Avenue, Suite 650
Minneapolis MINNESOTA US
CEO: Nadim Yared
Employees: 206
Phone: 17634162850
CVRX INC / CVRX FAQ
Can you describe the business of CVRX INC?
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company is headquartered in Minneapolis, Minnesota and currently employs 206 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The firm's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
What is the stock price of CVRX INC today?
The current stock price of CVRX is 10.19 USD. The price decreased by -4.23% in the last trading session.
Does CVRX stock pay dividends?
CVRX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CVRX stock?
CVRX has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting CVRX stock to perform?
13 analysts have analysed CVRX and the average price target is 11.83 USD. This implies a price increase of 16.11% is expected in the next year compared to the current price of 10.19.
What is the employee count for CVRX stock?
CVRX INC (CVRX) currently has 206 employees.
What is CVRX INC worth?
CVRX INC (CVRX) has a market capitalization of 266.47M USD. This makes CVRX a Micro Cap stock.
CVRX Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CVRX. When comparing the yearly performance of all stocks, CVRX turns out to be only a medium performer in the overall market: it outperformed 53.94% of all stocks.
CVRX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CVRX. CVRX has a bad profitability rating. Also its financial health evaluation is rather negative.
CVRX Financial Highlights
Over the last trailing twelve months CVRX reported a non-GAAP Earnings per Share(EPS) of -2.1. The EPS increased by 17.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.7% | ||
| ROE | -90.19% | ||
| Debt/Equity | 0.85 |
CVRX Forecast & Estimates
13 analysts have analysed CVRX and the average price target is 11.83 USD. This implies a price increase of 16.11% is expected in the next year compared to the current price of 10.19.
For the next year, analysts expect an EPS growth of 23.03% and a revenue growth 9.98% for CVRX